DrugDashboards

Clindamycin Phosphate and Benzoyl Peroxide

clindamycin phosphate and benzoyl peroxide · Kit · Mylan Pharmaceuticals Inc.

NDC 00378-8688-54 · 1 KIT in 1 CARTON * 10 g in 1 BOTTLE, PLASTIC * 40 g in 1 JAR · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is down 21% over the past year, to $0.4661 per gram. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4661per GMinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$24.12per package of 50GMMylan Pharmaceuticals, Inc. · Jan 1, 2023

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Nov 2013Sep 2026$0.4661
154 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$150.00
Reported to Texas DSHS · 2026 annual filing · Mylan Pharmaceuticals Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$575,959
12,863 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

38Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30
  • price down 25% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clindamycin phosphate and benzoyl peroxide (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA065443
TE code
AB
Approval date
Aug 11, 2009
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of clindamycin phosphate and benzoyl peroxide (Kit)

LabelerStrengthFirst seenLast seen
Mylan Pharmaceuticals Inc.Jul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clindamycin Phosphate and Benzoyl Peroxide — NDC 00378-8688-54," retrieved September 3, 2026, https://drugdashboards.com/drug/00378868854.

Free to cite with attribution — see how the data is put together.